Identification and treatment of latent tuberculosis infection (LTBI) can substantially reduce
the risk of developing active disease. However, there is no diagnostic gold standard for LTBI …

Diagnosis of tuberculosis, and especially the diagnosis of extrapulmonary tuberculosis, still
faces challenges in clinical practice. There are several reasons for this. Methods based on …

Globally, tuberculosis (TB) still remains a major public health problem. India is a high TB
burden country contributing to 26 per cent of global TB burden. During 1944-1980, TB …

Tuberculosis (TB) remains one of the most devastating infectious diseases and its
eradication is still unattainable given the limitations of current technologies for diagnosis …

Because most humans resist Mycobacterium tuberculosis infection, there is a paucity of lung
samples to study. To address this gap, we infected Diversity Outbred mice with M …

We present the effectiveness of Raman spectroscopy (RS) in combination with machine
learning for screening and analysis of blood sera collected from tuberculosis patients. Blood …

The respiratory fluoroquinolones moxifloxacin, gemifloxacin, and high-dose levofloxacin are
recommended in guidelines for effective empirical antimicrobial therapy of community …

Туберкулез является значимой проблемой общественного здравоохранения как в
России, так и в мире. Около 1/3 населения мира инфицировано микобактериями …

Background Effector CD4 T cells represent a key component of the host's anti-tuberculosis
immune defense. Successful differentiation and functioning of effector lymphocytes protects …

In the United States, latent tuberculosis infection (LTBI) affects between 10 and 15 million
people, of whom 10% may develop active tuberculosis disease. People at increased risk for …